Study to Nivolumab Following Preoperative Chemoradiotherapy

NCT02948348 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Cancer of Rectum

Interventions

DRUG: Nivolumab
DRUG: Ipilimumab

Sponsor

Takayuki Yoshino

Collaborators

[object Object]